Memphis Pharmaceutical & Chemical Industries (MPCI) Key Statistics
26 reported figures for Memphis Pharmaceutical & Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 6.26B
- P/E (trailing)
- 12.07
- P/B
- 8.12
- Dividend yield (FY 2025)
- 4.8%
Income (latest fiscal year)
- Revenue
- EGP 1.51B
- Net income
- EGP 505.28M
- EBITDA
- EGP 597.02M
- Free cash flow
- EGP 197.98M
- Profit margin
- 33.51%
Balance sheet
- Total assets
- EGP 1.49B
- Total debt
- EGP 66.63M
- Book value
- EGP 816.69M
Growth
- Revenue growth
- 72.93%
- Profit growth
- 163.91%
- EPS growth
- 96.01%
Per share
- EPS (fiscal year)
- 22.21
- Book value per share
- 35.9
- Dividend per share
- 13.187
- Return on equity
- 109.89%
- Return on assets
- 37.29%
Technical
- RSI (14)
- 33.9
- 50-day moving average
- EGP 369.06
- 200-day moving average
- EGP 240.13
- Beta (1Y)
- 0.58
Shares
- Shares outstanding
- 22.75M
- Free float
- 21.48%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.